Loading provider…
Loading provider…
Hematology & Oncology Physician in New Haven, CT
NPI: 1184999336Primary Practice Location
YALE-NEW HAVEN HOSPITAL
35 Park St, New Haven, CT
Primary Employer
Yale Medicine
yalemedicine.org
HQ Phone
Get MD Michael's Phone Numberphone_androidMobile
Get MD Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCT State Medical License
Albert Einstein College of Medicine of Yeshiva University
Medical School
Until 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 61 | 191 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 30 | 54 |
| 3 | 99223Initial hospital inpatient care, typically 70 minutes per day | 27 | 27 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 11 | 18 |
Epidemiology, treatment and outcomes of gastroenteropancreatic neuroendocrine neoplasms.
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Authors: Kert Sabbath, Jaykumar Thumar, Stacey Stein, Navid Hafez, Jonathan Sporn, Can Cui, Jill Lacy, Jeremy Kortmansky
Journal: Cancer
Publication Date: 2020-12-22
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Olaparib, BIOLOGICAL: Ramucirumab
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, DRUG: Topotecan Hydrochloride, PROCEDURE: Computed Tomography, PROCEDURE: Biopsy, DRUG: Irinotecan Hydrochloride, DRUG: Elimusertib
Lead Sponsor: Yale University
Intervention / Treatment: DRUG: Temozolomide + Olaparib